UK to pursue deals and acquisitions despite Brexit uncertainty
The UK pharmaceutical industry is pressing ahead with M&A activity and is “geared to weather any disruption due to Brexit”, suggest results of a recent survey by EY.
Read More
Tag: acquisitions
Astellas completes 800 million euro biotech acquisition
Belgium’s Ogeda is now a wholly-owned subsidiary of the Japanese pharma firm
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
